Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating Activities:
Net loss	$ (92,644)	$ (147,452)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for credit loss	150	74
Loss on sublease	510	0
Depreciation and amortization	12,735	11,884
Amortization-debt issuance costs and investment discount	1,608	1,681
Amortization of payment-in-kind interest	2,943	3,118
Equity-based compensation and common stock payments	58,833	81,786
Non-cash lease expense	2,151	2,001
Loss on extinguishment of debt	2,196	0
Changes in operating assets and liabilities:
Accounts receivable	(29,840)	(6,731)
Prepaid expenses and other current assets	(8,742)	(11,829)
Other assets	(137)	8
Medical expenses payable	45,509	15,402
Accounts payable and accrued expenses	2,030	(539)
Deferred premium revenue	116,298	96
Accrued compensation	7,484	4,638
Lease liabilities	(3,126)	(2,779)
Payment-in-kind interest	(14,122)	0
Net cash provided by (used in) operating activities	103,836	(48,642)
Investing Activities:
Purchase of business, net of cash received	(2,393)	0
Asset acquisition, net of cash received	0	(1,405)
Purchase of investments	(2,825)	(2,475)
Sale of investments	2,425	1,425
Acquisition of property and equipment	(17,317)	(15,409)
Net cash used in investing activities	(20,110)	(17,864)
Financing Activities:
Repurchase of noncontrolling interest	(100)	15
Equity repurchase	0	(1,474)
Issuance of long-term debt	165,000	0
Debt issuance costs	(4,601)	0
Repayment of long-term debt	(143,179)	0
Issuance of common stock	0	390,600
Common stock issuance costs	0	(29,011)
Net cash provided by financing activities	17,120	360,130
Net increase in cash	100,846	293,624
Cash and restricted cash at beginning of period	468,350	207,811
Cash and restricted cash at end of period	569,196	501,435
Supplemental disclosure of cash flow information:
Cash paid for interest	22,447	8,193
Supplemental non-cash investing and financing activities:
Acquisition of property in accounts payable	290	438
Purchase of business in accounts payable	375	0
Reconciliation of cash, cash equivalents and restricted cash as shown in the statement of cash flows:
Cash	567,446	500,485
Restricted cash in other assets	1,750	950
Total	$ 569,196	$ 501,435